Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by Tson99on Feb 11, 2012 6:36pm
370 Views
Post# 19521153

Financing??

Financing??

 

I guess that answers the question of financing. Beech was right again.

In the company’s most recent Management Discussion and Analysis, CEO Graeme McRae said Bioniche’s cash position is currently much higher than the Q2 statement because of an outstanding payable of $2.75 million from the Business Development Bank of Canada. This means Bioniche actually has $9.65 million in the bank, not the $6.9 million that was reported. The second reason is that the company now expects to reach a zero burn rate by the end of fiscal 2013. But Bioniche’s renewed focus on its animal health division may, in fact, allow them to do this even more quickly. Q2, 2012 sales of animal health products increased in the quarter by to $7.4 million, up $1.3 million as compared with the same quarter in fiscal 2011. Bioniche management says it has already pulled its burn rate down to $1 million a month in Q2, from the $1.2 it was burning in Q1.

Despite the improved situation of the balance sheet, Mcrae says the company does intend to seek a non-dilutive financing, such as a revolving credit facility or royalty stream debt financing, in the upcoming months.

Tson99

Bullboard Posts